Caprelsa (vandetanib) - Esteve
Retevmo (selpercatinib) - Eli Lilly
Radioembolization in PediatricOnset Sporadic Medullary Thyroid Carcinoma: A Rare Case Report (EANM 2026) - Sep 29, 2026 - Abstract #OP-696; Pres time: Oct 20, 2026; 03:00 PM - 04:30 PM; Location: Hall F1; "Disease progression with liver, bone and lung metastases was subsequently managed with vandetanib, followed by selpercatinib, which was maintained throughout subsequent treatments. In this case of pediatriconset sporadic MTC with liverdominant oligoprogression, ⁹⁰Y TARE achieved a clinically meaningful biochemical and radiological response with a favourable safety profile. To our knowledge, this represents the first reported use of TARE in liver metastases from pediatriconset sporadic MTC, supporting its consideration as a safe and effective locoregional option in selected cases. Longer follow-up is warranted." 
Case report • Clinical • Oncology • Pediatrics • Solid Tumor • Thyroid Gland Carcinoma • Thyroid Gland Medullary Carcinoma
https://www.sciencedirect.com/science/article/pii/S3051291326002855?via%3Dihub
 
N. Vasconcelos; D. Silva; R. Marão; R. Lopes; M. Arantes; F. Leite; L. Violante; I. Lucena Sampaio
 
Sep 29, 2026
 
Prev Next